Literature DB >> 3887000

A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group.

.   

Abstract

In this study, we have evaluated 50 children (30 girls and 20 boys; mean age, 10.1 years) with a variety of renal diseases in whom renal biopsy specimens showed crescents in greater than or equal to 50% of glomeruli. Initial clinical features included edema in 61%; hypertension in 51%; gross hematuria in 73%; 3 to 4+ proteinuria in 78%; and severely decreased GFR (less than 30 ml/min/1.73 m2) in 66%. When the total number of patients was divided into those with 50 to 79% crescents (N = 18) and those with 80 to 100% crescents (N = 32), no significant difference in outcome could be demonstrated, with endstage renal disease (ESRD) being seen in 44 and 52% of the two groups, respectively. Pathologic features associated with a poor prognosis included predominance of large crescents (P = 0.004) or fibrous crescents (P = 0.03); increased frequency of gaps in Bowman's capsule (P = 0.004); global glomerular sclerosis (P = 0.05); glomerular IgM (P = 0.003); interstitial fibrosis (P = 0.03); and tubular atrophy (P = 0.04). At followup, GFR was normal in all patients with poststreptococcal GN, but low in 60% of patients with other conditions. The study permits the following conclusions: (1) Approximately 50% of children with crescents in 50% or more glomeruli progress to ESRD; (2) a poor prognosis is associated with (a) a high percentage of large crescents, (b) increased frequency of gaps in Bowman's capsule, and (c) evidence of chronic histologic changes, but not with the percentage of crescents per se; and (3) the underlying type of glomerulonephritis is considered a helpful prognostic indicator.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3887000     DOI: 10.1038/ki.1985.30

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

Review 1.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 2.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

3.  Immunoperoxidase autopsy study of crescentic glomerulonephritis with extracapillary proliferation.

Authors:  T Tóth
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 4.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 5.  Trials and tribulations of multicenter studies. Lessons learned from the experiences of the Southwest Pediatric Nephrology Study Group (SPNSG).

Authors:  R J Hogg
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

6.  Acute postinfectious crescentic glomerulonephritis: clinicopathologic presentation and risk factors.

Authors:  Amr A El-Husseini; Hussein A Sheashaa; Alaa A Sabry; Fatma E Moustafa; Mohamed A Sobh
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

7.  Crescentic glomerulonephritis in children.

Authors:  H M Jardim; J Leake; R A Risdon; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

8.  Impact of clinical and histopathological factors on outcome of Egyptian patients with crescentic glomerulonephritis.

Authors:  A A El-Husseini; A E El-Agroudy; F E Moustafa; M A Fouda; M A Sobh
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

9.  Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children.

Authors:  William Wong; Maxwell Clarke Morris; Jonathan Zwi
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

10.  Diagnostic yield of renal biopsies: a retrospective single center review.

Authors:  Bari Scheckner; Alexandra Peyser; Jacob Rube; Freya Tarapore; Rachel Frank; Suzanne Vento; Cathy Hoffman; Elsa Valderrama; Douglas Charney; Beatrice Goilav; Howard Trachtman
Journal:  BMC Nephrol       Date:  2009-05-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.